Li Zhu

Li Zhu

Auto-generated profile, based on publicly available information

Li Zhu

Department of Ophthalmology Peking University People's Hospital Beijing China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2012 in Stem Cells and Development
Verified
Journal Article
Closed access
JLJing Li
Jing Li
LZLi Zhu
Li Zhu
XQXuebin Qu
Xuebin Qu
RLRuizhu Lin
Ruizhu Lin
LLLianming Liao
Lianming Liao
RZRobert Chunhua Zhao
Robert Chunhua Zhao
Pancreatic progenitor (PP) cells are tissue-committed cells, which can differentiate into all kinds of pancreatic cells. They are potential candidates for regeneration of pancreatic tissue. However, it is unfeasible to acquire PP cells from pancreatic tissues and expand them in vitro. Generation of PP cells from adipose tissue-derived mesenchymal stem cells (AD-MSCs) would provide an unlimited source of PP cells. Here we developed a 2-step stepwise protocol, which induced AD-MSCs to generate FOXA2- or SOX17-positive definitive endoderm (DE) (5 days) and pancreatic and duodenal homeobox gene 1 (PDX1)-positive PP cells (4–6 days). By mimicking the developmental progress in embryonic development, we optimized the timing and combination of cytokines to activate the key signaling pathways during pancreatic development. We found that activating the Nodal/Activin signal with Activin A could induce differentiation of AD-MSCs toward DE, which could be further promoted by the Wnt signaling pathway activator Wnt3a. Besides, transient T (BRACHYURY) + mesendodermal cells were observed during formation of DE from AD-MSCs. Subsequently, the Wnt signaling pathway inhibitor Dkk1 along with retinoic acid/FGF2 (60 ng/mL) further induced AD-MSC-derived DE cells to differentiate into PDX1-positive PP cells. The derived PP cells were capable to form pancreatic endocrine or exocrine cells. In conclusion, we established a stepwise protocol that could derive DE and PP cells from AD-MSCs. It might provide an unlimited source of autologous PP cells for pancreatic diseases.

24 September 2014 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
XYXiaoya Yang
Xiaoya Yang
ZLZhu Li
Zhu Li
YMYintu Ma
Yintu Ma
JGJun Gao
Jun Gao
SLSurui Liu
Surui Liu
GWGengyin Wang
Gengyin Wang
Human umbilical cord blood derived-mesenchymal stem cells (hUCMSCs) offer an attractive alternative to bone marrow-derived MSCs (BMMSCs) for cell-based therapy as it is a less invasive source of biological material. However, limited studies have been conducted with hUCMSCs as compared to BMMSCs. The present study was conducted to evaluate the effects of hUCMSCs in esophageal carcinoma (EC). hUCMSCs together with EC cells were transplanted subcutaneously into BALB/c nude mice to observe the effects of hUCMSCs on tumor establishment. hUCMSCs injected through the caudal vein to the mice with pre-established EC to observe the effects of hUCMSCs on tumor outgrowth. In order to elucidate the underlying mechanisms, we also performed in vitro experiments including directly co-culture, transwell assay, proliferation assay and western blotting analysis. hUCMSCs promoted EC formation in nude mice. In the in vivo model of pre-established EC, intravenously injected hUCMSCs potently promoted tumor growth. When in vitro co-cultured with hUCMSCs, EC cells proliferation increased. After co-cultured with hUCMSCs through transwell system, EC cells showed increased proliferation. Through transwell assay, we also observed that EC cells recruited MSCs, and MSCs promoted EC cells migration and invasion. Western blotting data showed that the expressions of proliferation related proteins Bcl-2, survivin and metastasis related proteins MMP-2 and MMP-9 were up-regulated in the EC cells transwell co-cultured with hUCMSCs. Our results indicated that hUCMSCs could favor tumor growth in vivo and in vitro. Thus, the exploitation of hUCMSCs in new therapeutic strategies should be cautious under the malignant conditions.

11 September 2018 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
HLHongling Li
Hongling Li
LZLi Zhu
Li Zhu
HCHuimin Chen
Huimin Chen
TLTangping Li
Tangping Li
QHQin Han
Qin Han
CZChunhua Zhao
Chunhua Zhao
Cell transplantation holds considerable promise for end‐stage liver diseases but identifying a suitable, transplantable cell type has been problematic. Here, we describe a novel type of mesenchymal stem cells (MSCs) from human adipose tissue. These cells are different from previously reported MSCs, they are in the euchromatin state with epigenetic multipotency, and express pluripotent markers MYC, KLF4, and GMNN. Most of the genes associated with germ layer specification are modified by H3K4me3 or co‐modified by H3K4me3 and H3K27me3. We named this new type of MSCs as adult multipotent adipose‐derived stem cells (M‐ADSCs). Using a four‐step nonviral system, M‐ADSCs can be efficiently Induced into hepatocyte like cells with expression of hepatocyte markers, drug metabolizing enzymes and transporters, and the other basic functional properties including albumin (ALB) secretion, glycogen storage, detoxification, low‐density lipoprotein intake, and lipids accumulation. In vivo both M‐ADSCs‐derived hepatoblasts and hepatocytes could form vascularized liver‐like tissue, secrete ALB and express metabolic enzymes. Single‐cell RNA‐seq was used to investigate the important stages in this conversion. M‐ADSCs could be converted to a functionally multipotent state during the preinduction stage without undergoing reprogramming process. Our findings provide important insights into mechanisms underlying cell development and conversion. Stem Cells Translational Medicine 2018;1–14

28 October 2024 in The FASEB Journal
Verified
Journal Article
Open access
YGYue Guo
Yue Guo
SCSitong Chen
Sitong Chen
WGWenxue Guan
Wenxue Guan
NXNingda Xu
Ningda Xu
LZLi Zhu
Li Zhu
MZMingwei Zhao
Mingwei Zhao
The intake of high dietary fat has been correlated with the progression of age‐related macular degeneration (AMD), affecting the function of the retinal pigment epithelium through oxidative stress. A high‐fat diet (HFD) can lead to lipid metabolism disorders, excessive production of circulating free fatty acids, and systemic inflammation by aggravating the degree of oxidative stress. Deletion of the retinal G‐protein‐coupled receptor (RGR‐d) has been identified in drusen. In this study, we investigated how the RGR‐d exacerbates AMD‐like changes under oxidative stress, both in vivo and in vitro. Fundus atrophy became evident, at 12 months old, particularly in the RGR‐d + HFD group, and fluorescence angiography revealed narrower retinal vessels and a reduced perfusion area in the peripheral retina. Although rod electroretinography revealed decreasing trends in the a‐ and b‐wave amplitudes in the RGR‐d + HFD group at 12 months, the changes were not statistically significant. Mice in the RGR‐d + HFD group showed a significantly thinner and more fragile retinal morphology than those in the WT + HFD group, with disordered and discontinuous pigment distribution in the RGR‐d + HFD mice. Transmission electron microscopy revealed a thickened Bruch's membrane along the choriocapillaris endothelial cell wall in the RGR‐d + HFD mice, and the outer nuclear layer structure appeared disorganized, with reduced nuclear density. Kyoto Encyclopedia of Genes and Genomes pathway analysis indicated significantly lower levels of 25(OH)‐vitamin D3 metabolites in the RGR‐d + HFD group. Under oxidative stress, RGR‐d localized to the mitochondria and reduced the levels of the PINK1–parkin pathway. RGR‐d mice fed an HFD were used as a new animal model of dry AMD. Under high‐fat‐induced oxidative stress, RGR‐d accumulated in the mitochondria, disrupting normal mitophagy and causing cellular damage, thus exacerbating AMD‐like changes both in vivo and in vitro.

17 April 2018 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
HXHui Xu
Hui Xu
LZLi Zhu
Li Zhu
YWYu Wang
Yu Wang
YBYongzhen Bao
Yongzhen Bao
Purpose. Secondary open-angle glaucoma may develop as a postoperative complication of early childhood cataract surgery. Its mechanism is poorly understood. Surgical removal of cataracts is typically incomplete, and we estimate that this disease is associated with alpha-B crystallin (CRYAB) secreted from the retained lens material. This study, for the first time, focused on the role of CRYAB in undesired changes of the structures and functions in trabecular meshwork (TM) cells.Methods. Cell proliferation and migration were assessed using a cell counting kit-8 (CCK8) and transwell assay analysis, respectively. Immunofluorescence (IF), quantitative real-time PCR (Rt-qPCR), and Western blot were performed to determine the effect of CRYAB on F-actin, tight junctions, and the expression of epithelial to mesenchymal transition- (EMT-) associated proteins in TM cells.Results. CRYAB promoted proliferation (p<0.0001), migration (p<0.001), and F-actin reorganization in TM cells. There were statistically significant increases in the mRNA and protein levels of zo-1, cadherin-N, and vimentin (allp<0.0001) and cadherin-E decreased (p<0.0001) and the mRNA level of claudin-1 increased (p<0.0001) compared to those of the control group.Conclusion. All of the changes in structures and functions first observed in the TM cells after exposure to CRYAB resembled alterations seen in primary open-angle glaucoma, suggesting that CRYAB might be related to the pathogenesis of secondary open-angle glaucoma after congenital cataract surgery.

1 June 2015 in Clinical Trials and Regulatory Science in Cardiology
Verified
Journal Article
Open access
PDF file
XZXin-Lin Zhang
Xin-Lin Zhang
QZQing-Qing Zhu
Qing-Qing Zhu
LZLi Zhu
Li Zhu
SSSu-Qin Shi
Su-Qin Shi
JCJian-Zhou Chen
Jian-Zhou Chen
BXBiao Xu
Biao Xu
Background: The appropriate duration of dual antiplatelet therapy (DAPT) with aspirin and a thienopyridine following drug-eluting stenting in percutaneous coronary intervention (PCI) remains uncertain. Methods and results A systemic search was conducted in PubMed, EMBASE and the Cochrane Central Register of Controlled Trials (CENTRAL), for randomized trials evaluating the relative efficacy and safety performance of an extended with a control duration DAPT after drug-eluting stents (DES) implantation. Ten trials including 32,135 patients were included. Compared with DAPT of 3 to 6 months, an extended DAPT duration of 12 months or longer significantly increased risk of major bleeding by 90% (RR: 1.90, 95% CI: 1.23 to 2.94, p = 0.004), but did not reduced incidences of any documented ischemic events. Compared with 12-month duration, a more extended DAPT (18 to 30 months) significantly increased risk of all-cause death (RR: 1.30, 95% CI: 1.02 to 1.65, p = 0.035) and major bleeding (RR: 1.61, 95% CI: 1.25 to 2.07, p < 0.001), decreased risk of myocardial infarction (RR: 0.53, 95% CI: 0.43 to 0.66, p < 0.001) and stent thrombosis (RR: 0.33, 95% CI: 0.21 to 0.51, p < 0.001), no difference was detected regarding cardiac death and stroke. Conclusions: A short DAPT (3 to 6 months) decreases major bleeding while maintains antithrombotic efficacy compared with an extended DAPT (≥ 12 months). A more extended DAPT (18 to 30 months) decreases ischemic events, whereas increases risks of all-cause death and major bleeding than standard 12-month therapy. A 3-to-6-month DAPT might be preferable for a broad group of patients undergoing DES implantation.